ArticleMolecular therapy. Methods & clinical development2022

Improved engraftment and therapeutic efficacy by human genome-edited hematopoietic stem cells with Busulfan-based myeloablation.

Edina Poletto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.